logo-loader
viewCytovia

Cytovia Therapeutics reveals two major partnerships

Cytovia Therapeutics CEO Daniel Teper sat down with Proactive’s Christine Corrado at the BIO CEO & Investor Conference in New York. The company recently announced two major partnerships: one with the New York Stem Cell Foundation Research Institute, and the other with the University of California - San Francisco.

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

OptiBiotix Health secures significant exclusive licence agreement for OptiBiome

OptiBiotix Health PLC's (LON:OPTI) Stephen O'Hara chats to Proactive's Andrew Scott after signing an exclusive licence agreement for its OptiBiome weight loss ingredient with Australian firm OptiPharm Pty Ltd. OptiPharm owns Optislim, the number one weight management brand in Australia, which...

9 hours, 34 minutes ago

2 min read